RxSight, Inc. (RXST)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$6.38-2.45%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · RXST
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(25.0) + peer(0.2*0.4) + term(0.0) → 8.82% (capped ±15.0)
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition. On August 5, 2026, RxSight, Inc. (the “ Company ” ) issued a press release announcing its results of operations and financial condition for the three months ended June 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information furnished in this Current Report on Form 8-K under
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operations and Financial Condition. On July 6, 2026, RxSight, Inc. (the “Company”) issued a press release announcing certain preliminary unaudited second quarter financial and operational results. A copy of the press release is furnished herewith as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On May 6, 2026, RxSight, Inc. (the “ Company ” ) issued a press release announcing its results of operations and financial condition for the three months ended March 31, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On February 25, 2026, RxSight, Inc. (the “ Company ” ) issued a press release announcing its results of operations and financial condition for the three and twelve months ended December 31, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On January 11, 2026, RxSight, Inc. (the “Company”) issued a press release announcing certain preliminary unaudited fourth quarter and full-year 2025 financial and operational results. A copy of the press release is furnished herewith as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On November 5, 2025, RxSight, Inc. (the “ Company ” ) issued a press release announcing its results of operations and financial condition for the three and nine months ended September 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On August 7, 2025, RxSight, Inc. (the “ Company ” ) issued a press release announcing its results of operations and financial condition for the three and six months ended June 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On July 8, 2025, RxSight, Inc. (the “Company”) issued a press release announcing certain preliminary unaudited second quarter financial and operational results. A copy of the press release is furnished herewith as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On May 7, 2025, RxSight, Inc. (the “ Company ” ) issued a press release announcing its results of operations and financial condition for the three ended March 31, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On April 2, 2025, RxSight, Inc. (the “Company”) issued a press release announcing certain preliminary unaudited first quarter financial and operational results. A copy of the press release is furnished herewith as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On February 25, 2025, RxSight, Inc. (the “ Company ” ) issued a press release announcing its results of operations and financial condition for the three and twelve months ended December 31, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On January 12, 2025, RxSight, Inc. (the “Company”) issued a press release announcing certain preliminary unaudited fourth quarter and full-year 2024 financial and operational results. A copy of the press release is furnished herewith as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On November 7, 2024, RxSight, Inc. (the “ Company ” ) issued a press release announcing its results of operations and financial condition for the three and nine months ended September 30, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On August 5, 2024, RxSight, Inc. (the “ Company ” ) issued a press release announcing its results of operations and financial condition for the three and six months ended June 30, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On May 6, 2024, RxSight, Inc. (the “ Company ” ) issued a press release announcing its results of operations and financial condition for the three months ended March 31, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information furnished in this Current Report on Form 8-K under
Results of Operations and Financial Condition. On February 28, 2024, RxSight, Inc. (the “ Company ” ) issued a press release announcing its results of operations and financial condition for the three and twelve months ended December 31, 2023. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information furnished in this Current Report on Form 8-K under